Back Pain After Menopause: What Changed and What Helps?
By Deborah Westergaard, MD | Regen Experts | Dallas and Plano
You’re still exercising. You haven’t had an injury. Yet standing through dinner or walking your usual route has become uncomfortable. If you’re experiencing back pain after menopause, it is reasonable to ask what changed.
Hormonal changes may be part of the explanation. They are not a diagnosis by themselves.
The short answer: Menopause is associated with changes in spinal discs, bone, muscles, and pain-related biology. Much of the evidence is observational or comes from laboratory studies. The useful next step is to identify what is contributing to your symptoms and build a plan around those findings.
Why can back pain after menopause become more noticeable?
Several changes may overlap: altered disc and joint mechanics, changes in muscle support, bone health, and the way tissues and nerves respond to inflammation. Menopause may contribute, but age, previous injuries, activity, and other health conditions also matter.
A 2026 review by Chagas and colleagues examined 132 clinical, preclinical, and review articles. Its value is the broader view of the spine: discs, facet joints, supporting bone, ligaments, muscles, and pain pathways all deserve consideration. Its central limitation is equally important: most findings show associations rather than proof of cause and effect.
That distinction matters in the examination room. I want to understand why your back hurts now, what activities provoke it, and whether the examination and imaging tell a consistent story.
Your discs respond to biology and share the load
An intervertebral disc contains a water-rich center surrounded by a strong fibrous outer ring. Together, they help distribute forces between the vertebrae.
Disc cells contain estrogen receptors. Laboratory research suggests estrogen signaling can influence cell behavior and inflammatory pathways. That makes hormonal involvement biologically plausible; it does not establish that low estrogen caused an individual woman’s disc degeneration.
In an MRI study of 1,566 women and 1,382 men, postmenopausal women had more severe disc degeneration than the comparison groups. The association with years since menopause was evident within the first 15 years after menopause. These were people admitted for low back pain, not a random sample of all adults. The observational design also could not fully separate hormonal effects from other influences.
As a disc loses water and height, load distribution can change. The small facet joints behind the spine and the surrounding ligaments may then experience different stresses. A finding described as “disc degeneration” can therefore belong to a wider mechanical problem.
This is why I consider the spine as a functional unit when evaluating symptoms. It does not mean every abnormal structure needs treatment.
The bone beneath the disc and cartilage matters, too
The vertebral endplate is the interface between a disc and the vertebra. Its cartilage and underlying bone help transmit force and support nutrient exchange. Changes in this region can affect the surrounding tissues.
Facet joints also contain cartilage, underlying bone, and a joint lining. Increased loading can be accompanied by changes in all three. Research in animals suggests estrogen loss may influence facet degeneration, but animal findings cannot establish a preventive treatment for women.
There is another important limit: evidence that menopause specifically drives vertebral endplate degeneration is not robust. Anatomy, lifetime loading, aging, and hormonal changes are difficult to disentangle.
Bone health deserves its own attention. Osteoporosis and degenerative disc disease are different conditions. A possible vertebral fracture should not be dismissed as ordinary back pain or a menopausal symptom.
Inflammation and muscle support can change the experience of pain
Degenerative spinal tissues can release inflammatory substances that sensitize nearby nerves. Experimental research also suggests that estrogen signaling influences pain processing. These mechanisms are complex; they do not support a simple rule that a lower estrogen level always means more pain.
There is early laboratory evidence involving estrogen receptors in the ligamentum flavum, a ligament that can thicken and contribute to spinal narrowing. Whether menopause directly drives that process in women remains uncertain.
Muscle support deserves attention as well. The multifidus and other trunk muscles help control movement between spinal segments. Low back pain is associated with changes such as multifidus atrophy and fatty infiltration. Pain can also interfere with coordinated muscle activation.
The 2026 review identified a specific gap: it found no studies directly examining menopause’s effects on spinal muscles. Research on skeletal muscle more generally raises useful questions, but it cannot establish that menopause caused a particular patient’s multifidus changes.
My clinical takeaway is to assess strength and movement rather than assume the MRI has explained everything.
What the evidence does not establish
Most human studies in this field are observational. Many proposed mechanisms come from cell experiments or animals whose ovaries were removed. Those models help researchers investigate biology, but they do not reproduce every aspect of natural menopause.
Some studies did not adequately account for occupational loading, smoking, physical activity, or reproductive history. The review also identified weaknesses in reporting recruitment, blinding, and statistical power.
Evidence supporting hormone replacement therapy for low back pain remains inconclusive. Estrogen receptors in a disc do not prove that replacing estrogen prevents degeneration or treats back pain. Hormone decisions belong in a separate, individualized discussion with the clinician managing your menopausal care.
The review also discusses osteoporosis drugs, including parathyroid hormone analogues. That is not a recommendation to use them routinely for degenerative back pain. Their potential spine applications need better clinical evidence.
Finally, an MRI abnormality is not automatically the source of pain. A systematic review of imaging in people without symptoms found degenerative findings were common and became more frequent with age. Imaging can be very useful, but it must be interpreted alongside symptoms and examination.
Treat the patient, not simply the picture.
What can you do now?
Start with an assessment that connects your symptoms, examination, function, and relevant imaging. The question is which findings matter for you and what would reasonably help.
For many people with persistent low back pain, an individualized exercise program is a useful part of care. A Cochrane review of 249 trials supports exercise for chronic nonspecific low back pain, particularly compared with no treatment, usual care, or placebo. That evidence is not specific to menopausal women and does not show that exercise reverses disc degeneration.
Depending on the findings, a program may include progressive trunk and hip strengthening, endurance work, movement control, and tolerable aerobic activity. The starting point and progression should reflect your symptoms, bone health, and abilities. A generic exercise list is not a substitute for that judgment.
New or progressive leg weakness requires prompt assessment. New urinary retention, loss of bladder or bowel control, or saddle numbness requires emergency evaluation. Sudden severe back pain, particularly with osteoporosis or after a fall, also warrants timely assessment for fracture.
Whether rehabilitation, a selected procedure, or a surgical opinion belongs in the plan depends on the diagnosis. Menopause alone does not establish candidacy for an injection, orthobiologic treatment, or surgery.
Understand your options before committing
At Regen Experts in Dallas and Plano, I evaluate the structures and movement patterns that may be contributing to your symptoms, then explain which options fit the findings and where uncertainty remains.
If back pain is limiting activities that matter to you, request an Executive Joint Preservation Evaluation. The evaluation can help clarify whether a nonsurgical approach is appropriate or whether another referral is the better next step.
Treatment costs: Your evaluation is billed separately. If treatment is recommended, you receive an explanation of the proposed plan and an individualized cost estimate before committing to it.
Frequently asked questions
Does menopause cause back pain?
Menopause is associated with back pain and changes in several spinal tissues, but it is not a sufficient explanation for an individual person’s symptoms. Other causes and contributing factors still need to be evaluated.
Can low estrogen affect spinal discs?
Disc cells have estrogen receptors, and laboratory studies suggest hormonal signaling can affect disc biology. Observational studies also associate postmenopausal status with greater disc degeneration. These findings do not prove that low estrogen caused a specific patient’s degeneration.
Does hormone replacement therapy help back pain?
Evidence supporting hormone replacement therapy for low back pain remains inconclusive. It should not be presented as a proven way to prevent disc degeneration or treat degenerative back pain. Decisions about hormones require a separate assessment of menopausal symptoms, health history, benefits, and risks.
Does disc degeneration on MRI explain my pain?
Sometimes it contributes, but imaging alone cannot establish that conclusion. Degenerative findings also occur in people without pain. The location and pattern of symptoms, examination findings, and other possible pain sources matter.
What helps back pain after menopause?
Treatment depends on the cause. An individualized plan may include progressive exercise, rehabilitation, attention to bone health, and other condition-specific care. Evidence supports exercise for chronic nonspecific low back pain generally; it does not establish one program for every menopausal woman.
Chagas J, Gilmer G, Sowa G, Vo N. Impact of Menopause and Associated Hormonal Changes on Spine Health in Older Females: A Review. Cells. 2026;15(2):148. https://pmc.ncbi.nlm.nih.gov/articles/PMC12839056/ — Narrative review of 132 articles; use for the integrated biological explanation and explicit limitations. Not 132 clinical trials. Literature search through July 2025.
Lou C, et al. Association between menopause and lumbar disc degeneration: an MRI study of 1,566 women and 1,382 men. Menopause. 2017;24(10):1136–1144. https://pubmed.ncbi.nlm.nih.gov/28609385/ — Observational, symptomatic cohort. Association within the first 15 years after menopause does not mean that is the period of greatest hormonal fluctuation.
Brinjikji W, et al. Systematic literature review of imaging features of spinal degeneration in asymptomatic populations. AJNR. 2015;36:811–816. https://pubmed.ncbi.nlm.nih.gov/25430861/ — Supports clinical correlation, not the claim that imaging findings never matter.
Hayden JA, et al. Exercise therapy for chronic low back pain. Cochrane Database Syst Rev. 2021;9. https://pubmed.ncbi.nlm.nih.gov/34580864/ — General chronic nonspecific LBP evidence; no menopause-specific efficacy claim.


Comments